Lexaria Bioscience press releases
The latest press releases from Lexaria Bioscience (NASDAQ: LEXX), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Lexaria Bioscience release within minutes of publication.
- Listing
- NASDAQ: LEXX
- Latest release
- Nov 4, 2026
- On this page
- 20 newest releases
Latest Lexaria Bioscience press releases
- Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
Third pharmaceutical company relationship entered Kelowna, British Columbia – November 4, 2026 – TheNewswire - Lexaria Bioscience Corp. (Nasdaq: LEXX) (the “ Company ” or “ Lexaria ”), a global innova…
- Lexaria Celebrates its 70th Patent Award
New patents awarded in the US, Canada, and Europe IP protection for treatments for Epilepsy, Diabetes, and Hypertension Kelowna, British Columbia – TheNewswire - October 28, 2026 – Lexaria Bioscience…
- Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Kelowna, BC – October 21, 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ:LEXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, reports that full enrollment has been…
The first 3 are open to everyone. A free account shows the rest and emails you the next Lexaria Bioscience release the minute it is out.
PPN World is independent and not affiliated with Lexaria Bioscience. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Lexaria Bioscience press releases?+
How do I get an alert when Lexaria Bioscience publishes a press release?+
Is this Lexaria Bioscience's official newsroom?+
Know the minute Lexaria Bioscience publishes
Watch Lexaria Bioscience, its competitors and its sector in one live feed, with email alerts — on the free plan.